Top-News

Harpoon Therapeutics News

Aktie
WKN:  A3EUUE ISIN:  US41358P2056 US-Symbol:  HARP
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
3,31 Mio.
Marktkapitalisierung *
68,87 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 05.09.2023

Harpoon Therapeutics News

06.02.24 - PR Newswire
INVESTIGATION ALERT: Halper Sadeh LLC Investigates HARP, JNPR, TGAN, TAST
INVESTIGATION ALERT: Halper Sadeh LLC Investigates HARP, JNPR, TGAN, TAST PR Newswire
05.02.24 - PR Newswire
INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - BBAI, HARP, FGH, PGTI
INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - BBAI, HARP, FGH, PGTI PR Newswire
23.01.24 - PR Newswire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates HARP, JNPR, TGAN
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates HARP, JNPR, TGAN PR Newswire
16.01.24 - PR Newswire
SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates AMAM, AXNX, HARP, GRCL
SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates AMAM, AXNX, HARP, GRCL PR Newswire
12.01.24 - PR Newswire
ALERT: Juan Monteverde Encourages the Shareholders of PGTI, WAVD, HARP, VIA to Take Action
ALERT: Juan Monteverde Encourages the Shareholders of PGTI, WAVD, HARP, VIA to Take Action PR Newswire
10.01.24 - PR Newswire
Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to Contact Law Firm
Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to Contact Law Firm PR Newswire
08.01.24 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HARP, AMAM, AXNX
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HARP, AMAM, AXNX PR Newswire
08.01.24 - wallstreet:online Zentralredaktion
Aktie verdoppelt sich: Merck: Übernahme von Harpoon Therapeutics? Aufschlag von 118 Prozent pro Aktie!
Merck & Co führt Gespräche über den Kauf von Harpoon Therapeutics für rund 700 Millionen US-Dollar. Die Harpoon-​Aktie verdoppelt sich vorbörslich.Merck ist in Gesprächen, um ...
08.01.24 - PR Newswire
Shareholder Alert: Ademi LLP investigates whether Harpoon Therapeutics, Inc. has obtained a Fair Price in its transaction with Merck
Shareholder Alert: Ademi LLP investigates whether Harpoon Therapeutics, Inc. has obtained a Fair Price in its transaction with Merck PR Newswire
25.10.23 - PR Newswire
Thinking about buying stock in VinFast Auto, Ardelyx, Harpoon Therapeutics, Mind Technology, or Ault Alliance?
Thinking about buying stock in VinFast Auto, Ardelyx, Harpoon Therapeutics, Mind Technology, or Ault Alliance? PR Newswire
24.10.23 - PR Newswire
Thinking about buying stock in VinFast Auto, Ardelyx, Harpoon Therapeutics, Mind Technology, or Ault Alliance?
Thinking about buying stock in VinFast Auto, Ardelyx, Harpoon Therapeutics, Mind Technology, or Ault Alliance? PR Newswire
23.10.23 - PR Newswire
Thinking about buying stock in Sterling Infrastructure, Mereo BioPharma Group, RVL Pharmaceuticals, SeaStar Medical Holding, or Harpoon Therapeutics?
Thinking about buying stock in Sterling Infrastructure, Mereo BioPharma Group, RVL Pharmaceuticals, SeaStar Medical Holding, or Harpoon Therapeutics? PR Newswire
10.07.23 - PR Newswire
Replicate Bioscience Appoints Rachael Lester as Chief Business Officer
Replicate Bioscience Appoints Rachael Lester as Chief Business Officer PR Newswire
12.12.22 - PR Newswire
Thinking about buying stock in HTG Molecular Diagnostics, Harpoon Therapeutics, Acer Therapeutics, Aptevo Therapeutics, or Tonix Pharmaceuticals?
Thinking about buying stock in HTG Molecular Diagnostics, Harpoon Therapeutics, Acer Therapeutics, Aptevo Therapeutics, or Tonix Pharmaceuticals? PR Newswire
24.08.20 - PR Newswire
Thinking about buying stock in Gevo Inc, Foot Locker, Harpoon Therapeutics, Eyepoint Pharmaceuticals, or GameStop Corp.?
Thinking about buying stock in Gevo Inc, Foot Locker, Harpoon Therapeutics, Eyepoint Pharmaceuticals, or GameStop Corp.? PR Newswire
14.02.19 - PR Newswire
Arix Bioscience plc: Harpoon Closes Initial Public Offering
Arix Bioscience plc: Harpoon Closes Initial Public Offering PR Newswire
14.02.19 - PR Newswire
Arix Bioscience plc: Harpoon Closes Initial Public Offering
Arix Bioscience plc: Harpoon Closes Initial Public Offering PR Newswire

Newssuche

Videos

29.05.24 +24,01%
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »